shutterstock_1349461163_pavel_kapysh

Pavel Kapysh / Shutterstock.com

5 August 2021GenericsAlex Baldwin

Shionogi and Duchesnay add new patents to Osphena dispute

Pharmaceutical companies Shionogi and Duchesnay have filed a second lawsuit against Hetero labs, claiming that the company infringed two additional patents related to Osphena (Ospemifene)—a treatment for vaginal pain during sex.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Shionogi sues Aurobindo to halt Doribax generic

19 January 2015 Japanese pharmaceutical company Shionogi has sued Aurobindo Pharma in an attempt to stop the Indian generic drug maker from marketing a version of its antibiotic drug Doribax (doripenem) in the US.

Shionogi sues Hospira to block Doribax generic

19 April 2013 Japanese pharma Shionogi has brought a lawsuit against Hospira Inc to keep it from marketing a generic version of Shionogi’s Doribax, alleging it infringes one of the company’s patents.

More on this story

Shionogi sues Aurobindo to halt Doribax generic

19 January 2015 Japanese pharmaceutical company Shionogi has sued Aurobindo Pharma in an attempt to stop the Indian generic drug maker from marketing a version of its antibiotic drug Doribax (doripenem) in the US.

Shionogi sues Hospira to block Doribax generic

19 April 2013 Japanese pharma Shionogi has brought a lawsuit against Hospira Inc to keep it from marketing a generic version of Shionogi’s Doribax, alleging it infringes one of the company’s patents.

More on this story

Shionogi sues Aurobindo to halt Doribax generic

19 January 2015 Japanese pharmaceutical company Shionogi has sued Aurobindo Pharma in an attempt to stop the Indian generic drug maker from marketing a version of its antibiotic drug Doribax (doripenem) in the US.

Shionogi sues Hospira to block Doribax generic

19 April 2013 Japanese pharma Shionogi has brought a lawsuit against Hospira Inc to keep it from marketing a generic version of Shionogi’s Doribax, alleging it infringes one of the company’s patents.

More features

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent